Kulbay, M.; Tuli, N.; Mazza, M.; Jaffer, A.; Juntipwong, S.; Marcotte, E.; Tanya, S.M.; Nguyen, A.X.-L.; Burnier, M.N., Jr.; Demirci, H.
Oncolytic Viruses and Immunotherapy for the Treatment of Uveal Melanoma and Retinoblastoma: The Current Landscape and Novel Advances. Biomedicines 2025, 13, 108.
https://doi.org/10.3390/biomedicines13010108
AMA Style
Kulbay M, Tuli N, Mazza M, Jaffer A, Juntipwong S, Marcotte E, Tanya SM, Nguyen AX-L, Burnier MN Jr., Demirci H.
Oncolytic Viruses and Immunotherapy for the Treatment of Uveal Melanoma and Retinoblastoma: The Current Landscape and Novel Advances. Biomedicines. 2025; 13(1):108.
https://doi.org/10.3390/biomedicines13010108
Chicago/Turabian Style
Kulbay, Merve, Nicolas Tuli, Massimo Mazza, Armaan Jaffer, Sarinee Juntipwong, Emily Marcotte, Stuti Misty Tanya, Anne Xuan-Lan Nguyen, Miguel N. Burnier, Jr., and Hakan Demirci.
2025. "Oncolytic Viruses and Immunotherapy for the Treatment of Uveal Melanoma and Retinoblastoma: The Current Landscape and Novel Advances" Biomedicines 13, no. 1: 108.
https://doi.org/10.3390/biomedicines13010108
APA Style
Kulbay, M., Tuli, N., Mazza, M., Jaffer, A., Juntipwong, S., Marcotte, E., Tanya, S. M., Nguyen, A. X.-L., Burnier, M. N., Jr., & Demirci, H.
(2025). Oncolytic Viruses and Immunotherapy for the Treatment of Uveal Melanoma and Retinoblastoma: The Current Landscape and Novel Advances. Biomedicines, 13(1), 108.
https://doi.org/10.3390/biomedicines13010108
